Login to Your Account

Washington Roundup

CRS Weighs in on Need for Generic-Innovation Balance

By Mari Serebrov
Washington Editor

Friday, March 16, 2012
WASHINGTON – As more and more drugs fall off patent, Congress may need to reset the scales to maintain the proper balance of lower drug prices through access to generics and an environment that encourages innovation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription